Literature DB >> 21278886

Epidemiological characteristics of ovarian cancer in Korea.

Boyoung Park1, Sohee Park, Tae-Joong Kim, Seung Hyun Ma, Byoung-Gie Kim, Yong-Man Kim, Jae Weon Kim, Sokbom Kang, Jaehoon Kim, Tae Jin Kim, Keun-Young Yoo, Sue K Park.   

Abstract

OBJECTIVE: This study was conducted to examine recent trends in ovarian cancer incidence and mortality and secular trends in demographic factors in Korea.
METHODS: With the data from Korea Central Cancer Registry, International Agency for Research on Cancer, Korean Death Registry, and World Health Organization's Statistical Information System, we calculated age-standardized incidence and mortality rates for ovarian cancer. Also we estimated future incidence of ovarian and cervical cancer using linear regression model. To assess the demographic trend, data from national surveys in Korea or results from published papers were searched.
RESULTS: Ovarian cancer incidence rate was similar to that in women worldwide but lower than those in Western countries, and the trend has been increased steadily. Ovarian cancer-related mortality rates have been increasing in Korea, even though those in western and some Asian countries, such as China, have been decreasing. Age-specific incidence rate and mortality rate showed steep increases with advancing age. The incidence rate of ovarian cancer was estimated to surpass that of uterine cervix cancer in 2015. Korea showed rapid changes in nutritional, reproductive, and anthropometric factors.
CONCLUSION: These recent trends in ovarian cancer incidence and mortality may be partly attributed to gradual westernizing of life styles and to changes in socio-demographic behavior factors. In particular, the increasing trend in ovarian cancer mortality in Korea may be attributed to a real rise in mortality as well as, in part, a decline in misclassification bias related to an increase in the proportion of deaths confirmed by physician diagnosis.

Entities:  

Keywords:  Epidemiology; Incidence; Mortality; Ovarian neoplasms

Year:  2010        PMID: 21278886      PMCID: PMC3026303          DOI: 10.3802/jgo.2010.21.4.241

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  17 in total

Review 1.  Meat, fish, and ovarian cancer risk: Results from 2 Australian case-control studies, a systematic review, and meta-analysis.

Authors:  Fariba Kolahdooz; Jolieke C van der Pols; Christopher J Bain; Geoffrey C Marks; Maria Celia Hughes; David C Whiteman; Penelope M Webb
Journal:  Am J Clin Nutr       Date:  2010-04-14       Impact factor: 7.045

2.  Temporal trends in ovarian cancer: incidence and mortality across Europe.

Authors:  Wendy R Brewster
Journal:  Nat Clin Pract Oncol       Date:  2005-06

3.  Proportion of death certificates issued by physicians and associated factors in Korea, 1990-2002.

Authors:  Min Woo Jo; Young Ho Khang; Sungcheol Yun; Jin Yong Lee; Moo Song Lee; Sang Il Lee
Journal:  J Prev Med Public Health       Date:  2004-11

4.  Patterns in the incidence of age-related ovarian cancer in South East England 1967-1996.

Authors:  A Olaitan; A Mocroft; I Jacobs
Journal:  BJOG       Date:  2000-09       Impact factor: 6.531

5.  Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.

Authors:  V Beral; R Doll; C Hermon; R Peto; G Reeves
Journal:  Lancet       Date:  2008-01-26       Impact factor: 79.321

Review 6.  The epidemiology of ovarian cancer.

Authors:  F Parazzini; S Franceschi; C La Vecchia; M Fasoli
Journal:  Gynecol Oncol       Date:  1991-10       Impact factor: 5.482

7.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

Authors:  A S Whittemore; R Harris; J Itnyre
Journal:  Am J Epidemiol       Date:  1992-11-15       Impact factor: 4.897

8.  Age at menarche in a Korean population: secular trends and influencing factors.

Authors:  Geum Joon Cho; Hyun Tae Park; Jung Ho Shin; Jun Young Hur; Young Tae Kim; Sun Haeng Kim; Kyu Wan Lee; Tak Kim
Journal:  Eur J Pediatr       Date:  2009-06-07       Impact factor: 3.183

Review 9.  Common risk factors of breast and ovarian cancer: recent view.

Authors:  G C Zografos; M Panou; N Panou
Journal:  Int J Gynecol Cancer       Date:  2004 Sep-Oct       Impact factor: 3.437

10.  [Cancer registration in Korea: the present and furtherance].

Authors:  Yoon-Ok Ahn
Journal:  J Prev Med Public Health       Date:  2007-07
View more
  15 in total

1.  Conditional Relative Survival of Ovarian Cancer: A Korean National Cancer Registry Study.

Authors:  Dong Wook Shin; Jaeman Bae; Johyun Ha; Kyu-Won Jung
Journal:  Front Oncol       Date:  2021-04-28       Impact factor: 6.244

2.  Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.

Authors:  Se Ik Kim; Myong Cheol Lim; Jiwon Lim; Young Joo Won; Sang Soo Seo; Sokbom Kang; Sang Yoon Park
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

3.  CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation.

Authors:  Minhui Hua; Sujuan Yan; Yan Deng; Qinghua Xi; Rong Liu; Shuyun Yang; Jian Liu; Chunhui Tang; Yingying Wang; Jianxin Zhong
Journal:  Int J Mol Med       Date:  2015-02-04       Impact factor: 4.101

4.  High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer.

Authors:  Jinju Oh; Sung Hae Park; Tae Sung Lee; Hoon Kyu Oh; Jung Hye Choi; Youn Seok Choi
Journal:  J Gynecol Oncol       Date:  2014-07-06       Impact factor: 4.401

5.  Ovarian cancer mortality among women aged 40-79 years in relation to reproductive factors and body mass index: latest evidence from the Japan Collaborative Cohort study.

Authors:  Md Mobarak Hossain Khan; Aklimunnessa Khan; Masahiro Nojima; Sadao Suzuki; Yoshihisa Fujino; Shinkan Tokudome; Koji Tamakoshi; Mitsuru Mori; Akiko Tamakoshi
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

6.  Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study.

Authors:  Shin Hye Chung; Soo Yoon Lee; Woong Ju; Seung Cheol Kim
Journal:  Obstet Gynecol Sci       Date:  2013-07-15

7.  Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model.

Authors:  Hwa-Young Lee; Bong-Min Yang; Ji-Min Hong; Tae-Jin Lee; Byoung-Gie Kim; Jae-Weon Kim; Young-Tae Kim; Yong-Man Kim; Sokbom Kang
Journal:  Clinicoecon Outcomes Res       Date:  2013-07-03

8.  Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.

Authors:  Sae Hyun Park; Ji-Ye Song; Yu-Kyung Kim; Jin Hyung Heo; Haeyoun Kang; Gwangil Kim; Hee Jung An; Tae Hoen Kim
Journal:  Int J Oncol       Date:  2013-12-30       Impact factor: 5.650

9.  Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer.

Authors:  Jin-Young Park; Eun Jin Heo; Jeong-Won Lee; Yoo-Young Lee; Tae-Joong Kim; Byoung-Gie Kim; Duk-Soo Bae
Journal:  J Gynecol Oncol       Date:  2016-03       Impact factor: 4.401

10.  Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea.

Authors:  Boyoung Park; Sohee Park; Hai-Rim Shin; Aesun Shin; Yohwan Yeo; Ji-Yeob Choi; Kyu-Won Jung; Byoung-Gie Kim; Yong-Man Kim; Dong-Young Noh; Sei-Hyun Ahn; Jae Weon Kim; Sokbom Kang; Jae Hoon Kim; Tae Jin Kim; Daehee Kang; Keun-Young Yoo; Sue K Park
Journal:  BMC Cancer       Date:  2016-01-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.